Aptevo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.77

-0.03 (-0.52%)

As of May 16, 2:32 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +492.2% upside

Low Target $22.50

Average Target $28.25

High Target $48.31

Current Price $4.77

Current
$4.77

Target
$28.25

$22.50 $28.25 avg $48.31

Scenario Analysis

Bear Case

$22.50

371.7%

Low target

Base Case

$28.25

+492.2%

Avg target

Bull Case

$48.31

+912.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$258.12

-98.2% from high

52-Week Low

$3.80

+25.5% from low

Target vs 52W High

$28.25

-89.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%